These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3711651)

  • 1. Drug information: how much is too much? Suggestions for improving the sources of drug information.
    Devetski RL
    Indiana Med; 1986 Apr; 79(4):368-9. PubMed ID: 3711651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 3. [The enclosed notes with too much information].
    Weismann K; Larsen FG
    Ugeskr Laeger; 2001 Aug; 163(35):4762-4. PubMed ID: 11572057
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of medicines information for patient safety.
    Pappa D; Telonis P; Stergioulas LK
    J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
    Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
    Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hazardous drugs, high risk patients and high risk physicians].
    Karlmark B
    Lakartidningen; 1991 Nov; 88(48):4115. PubMed ID: 1956247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaca Fennica and the information about parallel pharmaceutical derivatives].
    Kettunen K
    Duodecim; 2003; 119(17):1686; author reply 1687. PubMed ID: 14587451
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interaction microcomputer software evaluation: Drug Therapy Screening System (DTSS).
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Aug; 25(8):738-41, 744. PubMed ID: 10170582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug control within the EEC II: good possibilities for Sweden].
    Strandberg K
    Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and coding considerations for drug data base design.
    Forbes MB
    J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426
    [No Abstract]   [Full Text] [Related]  

  • 14. [Self-assessment by physicians concerning their management of drug risks. Information sources, risk evaluation, problems and recommendations for improvements].
    Kemmnitz W
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):509-12. PubMed ID: 9842698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid drug information from the federal health office].
    Moll H
    Monatsschr Kinderheilkd; 1988 Jul; 136(7):400. PubMed ID: 3211173
    [No Abstract]   [Full Text] [Related]  

  • 16. [More information on drug package inserts and counseling replace the warning triangle].
    Beermann B; Liliemark J; Johansson K
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1918, 1921. PubMed ID: 16044776
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical drug information: a case of misinformation.
    Rowles B; Worthen DB
    N Engl J Med; 1982 Jan; 306(2):113-4. PubMed ID: 7053484
    [No Abstract]   [Full Text] [Related]  

  • 18. [Printed material distributed by pharmaceutical propaganda agents].
    Mejía R; Avalos A
    Medicina (B Aires); 2001; 61(3):315-8. PubMed ID: 11474880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on drug information centers in the United States.
    Rosenberg JM; Kirschenbaum HL; Labella NA
    Am J Hosp Pharm; 1981 Oct; 38(10):1522-4. PubMed ID: 7294053
    [No Abstract]   [Full Text] [Related]  

  • 20. [The specifics of drug information].
    Böhm M
    Pharmazie; 1983 Aug; 38(8):556-8. PubMed ID: 6634927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.